Sanofi Long Term Debt

Sanofi (SNYNF) currently reports a long-term debt of $16B as of June 2026. That compares with $15B in the prior-year period — up 10.9% year over year. Use the charts on this page to explore Sanofi's long-term debt history and peer comparisons.

Sanofi's long-term debt increased from $15B to $16B — a 10.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sanofi reported $16B in long-term debt as of June 2026. That compares with $15B in the prior-year period — up 10.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $16B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sanofi, and consider following SNYNF for alerts when major investors trade the stock.

Sanofi is classified in the Healthcare sector. On long-term debt, it currently shows $16B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNYNF with unrelated industries.